Charles River Laboratorie...

NYSE: CRL · Real-Time Price · USD
157.31
1.51 (0.97%)
At close: Aug 15, 2025, 1:11 PM

Charles River Laboratories International Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 28, 2024 Dec 30, 2023 Dec 31, 2022 Dec 25, 2021
Cash & Equivalents
194.61M 276.77M 233.91M 241.21M
Short-Term Investments
n/a n/a 998K 1.06M
Long-Term Investments
218.35M 243.81M 311.6M 201.35M
Other Long-Term Assets
278.23M 309.38M 148.28M 151.54M
Receivables
720.91M 780.38M 752.39M 642.88M
Inventory
278.54M 380.26M 255.81M 199.15M
Other Current Assets
105.8M 83.38M 107.58M 97.31M
Total Current Assets
1.4B 1.61B 1.44B 1.27B
Property-Plant & Equipment
2.02B 2.03B 1.86B 1.58B
Goodwill & Intangibles
3.57B 3.96B 3.81B 3.77B
Total Long-Term Assets
6.13B 6.59B 6.16B 5.75B
Total Assets
7.53B 8.2B 7.6B 7.02B
Account Payables
140.34M 168.94M 205.91M 198.13M
Deferred Revenue
248.32M 241.82M 264.26M 219.7M
Short-Term Debt
n/a n/a 50.2M 101K
Other Current Liabilities
337.04M 431.04M 334.23M 307.01M
Total Current Liabilities
994.1M 1.06B 1.09B 1.03B
Long-Term Debt
2.24B 2.65B 2.71B 2.92B
Other Long-Term Liabilities
195.21M 223.19M 149.03M -30.69M
Total Long-Term Liabilities
3.03B 3.48B 3.49B 3.4B
Total Liabilities
4.02B 4.54B 4.58B 4.43B
Total Debt
2.72B 3.07B 3.1B 2.92B
Common Stock
511K 513K 509K 505K
Retained Earnings
1.81B 1.89B 1.43B 980.75M
Comprehensive Income
-317.35M -196.43M -262.06M -164.74M
Shareholders Equity
3.46B 3.6B 2.98B 2.53B
Total Investments
218.35M 243.81M 311.6M 202.41M